Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

Launched by JANICE HERNANDEZ, MD · Jul 10, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a special type of wound dressing called a hydrocolloid dressing (specifically DuoDERM EXTRA THIN) to help heal wounds after certain facial surgeries, like Mohs surgery and reconstructive procedures around the eyes and face. The goal is to see if this dressing can replace the usual treatment, which often involves applying antibiotic ointment. Using this dressing might make it easier for patients to care for their wounds after surgery, as it would be placed right after the operation and then removed during a follow-up visit about one week later.

Adults over 18 years old who are having these types of surgeries and can attend follow-up visits at 1 week, 6 weeks, and 3 months may be eligible to join. People with allergies to certain ingredients in the dressing, those under 18 or over 100 years old, or those who cannot give informed consent cannot participate. If you join the study, you can expect the dressing to be applied immediately after your surgery and then removed during a check-up a week later, potentially reducing the need to use ointments and simplifying your post-surgery care. This study is currently recruiting participants and welcomes adults of all genders and backgrounds.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients \>18 years of age
• • follow-up at specified intervals (1 week/6 week/3 months) in an office setting
• • can give informed consent
• • no patients will be excluded on the basis of gender, ethnicity, or religious background
• Exclusion Criteria:
• • Patients \<18 years of age or \>100
• • allergy to pectin, gelatin, and sodium carboxymethylcellulose
• • adults with impaired consent capacity
• • incarcerated individuals.